Cellebrite DI (CLBT) — Cash Flow Reinvestment Rate
Cellebrite DI (CLBT) has a Cash Flow Reinvestment Rate of 1.20x as of December 2025, reinvesting $98.66 Million (capex $3.96 Million plus investments $-94.70 Million) from operating cash flow of $82.23 Million. Check CLBT cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cellebrite DI Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Cellebrite DI across 7 annual periods. Explore CLBT long-term investments to assets to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Cellebrite DI (2019–2025)
Year-by-year capital reinvestment analysis for Cellebrite DI. For live market cap and broader valuation context, see CLBT market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.71x | $120.79 Million | $168.96 Million | $13.22 Million | ▼ -41.0% |
| 2024 | 1.21x | $160.08 Million | $132.17 Million | $10.61 Million | ▲ +73.9% |
| 2023 | 0.70x | $71.06 Million | $102.06 Million | $7.92 Million | ▼ -85.7% |
| 2022 | 4.88x | $100.32 Million | $20.58 Million | $9.09 Million | ▲ +115.8% |
| 2021 | 2.26x | $81.45 Million | $36.05 Million | $8.11 Million | ▲ +616.9% |
| 2020 | 0.32x | $20.96 Million | $66.51 Million | $6.18 Million | ▼ -89.1% |
| 2019 | 2.90x | $46.72 Million | $16.13 Million | $6.21 Million | — |